Skip to content

Barbora Holubová

2 papers in the library · 11 citations · publishing 2018-2019

Papers

Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines.

Journal of pharmacological and toxicological methods January 1, 2019 Anna Šuláková, Lucie Fojtíková, Barbora Holubová et al. 11 citations

Two new immunoassays, a lateral flow immunoassay (LFIA) and an enzyme-linked immunosorbent assay (ELISA), were developed to detect the hallucinogenic phenethylamine 2C-B and related drugs in urine. The LFIA provides rapid on-site screening with a detection limit of 15 ± 7 ng mL⁻¹, suitable for identifying recent exposure. The ELISA offers much higher sensitivity, with a detection limit of 6 ± 3 pg mL⁻¹, and its results closely match those from established UHPLC-MS-MS analysis, making it reliable for quantitative confirmation in toxicology. Both methods address the need for simple, cost-effective tools to monitor these dangerous substances.

Use of novel haptens in the production of antibodies for the detection of tryptamines.

RSC advances April 27, 2018 Michal Maryška, Lucie Fojtíková, Radek Jurok et al.

Polyclonal antibodies produced in rabbits against novel haptens derived from tryptamine-based drugs—DMT, 5-MeO-DMT, and DiPT—show good reactivity and low detection limits (0.006-0.254 ng mL-1) in ELISAs, making them suitable for developing immunochemical assay kits to simplify detection of these hallucinogenic drugs in body fluids.